Baseline | Completed 6-month follow-up | Dropout at 6 months | |
Patients | 80 | 65 | 15 |
Age years | 68±9 69 (46–82) | 68±9 67 (51–82) | 68±11 0 (46–81) |
Males | 46 (58) | 39 (60) | 7 (47) |
COPD# | |||
Mild: FEV1 ≥80% pred | 8 (10) | 8 (12) | 0 |
Moderate: FEV1 50–80% pred | 15 (15) | 9 (14) | 6 (8) |
Severe: FEV1 30–50% pred | 6 (8) | 6 (9) | 0 |
Previous cancer diagnosis | 31 (40) | 24 (37) | 7 (44) |
Pack-years¶ | 35 (30) | 33 (28) | 47 (36) |
DLCO % pred | 67 (17) | 67 (16) | 67 (17) |
ASA physical status | |||
2 | 64 (80) | 52 (80) | 12 (80) |
3 | 16 (20) | 13 (20) | 3 (20) |
ECOG performance status | |||
0 | 51 (64) | 44 (68) | 7 (47) |
1 | 29 (36) | 21 (33) | 8 (53) |
Values are presented as n, mean±sd, median (minimum–maximum range) or n (%). COPD: chronic obstructive pulmonary disease; FEV1: forced expiratory volume in 1 s; DLCO: diffusing capacity of the lung for carbon monoxide; ASA: American Society of Anaesthesiologists; ECOG: Eastern Cooperative Oncology Group. #: n=29; ¶: n=72.